WMSA
GNMK

Weiss Multi-Strategy Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,000
Closed -$149K – 999
2014
Q1 		$149K Buy
+15,000
New +$186K ﹤0.01% 931
2013
Q3 		– Sell
-28,100
Closed -$291K – 1029
2013
Q2 		$291K Buy
+28,100
New +$387K 0.01% 603

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GNMK Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 18,000 shares — an estimated $256K sold.

Weiss Multi-Strategy Advisers first reported a position in GNMK in Q3 2013 and held it in 29 quarters. The position peaked at $1.66M in Q4 2013. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

  • Weiss Multi-Strategy Advisers reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 18,000 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $256K.
  • Weiss Multi-Strategy Advisers first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 29 quarters.
  • Weiss Multi-Strategy Advisers's GenMark Diagnostics, Inc position peaked at $1.66M in Q4 2013.
  • 151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.